-
Mylan gets FDA nod for generic Adalat CC
PITTSBURGH — The Food and Drug Administration has approved a generic drug for hypertension made by Mylan.
Mylan announced Friday the approval of nifedipine extended-release tablets in the 30-mg, 60-mg and 90-mg strengths. The drug is a generic version of Bayer’s Adalat CC.
Nifedipine tablets had sales of around $82 million during the 12-month period ended in June, according to IMS Health.
-
COPD now No. 3 leading cause of death among Americans
WASHINGTON — Chronic obstructive pulmonary disease is the third-leading cause of death in the United States, according to a new report by the Centers for Disease Control and Prevention.
The CDC’s National Center for Health Statistics released the report Friday, which showed that COPD became the third-leading cause of death in 2008, but it was expected to reach that rank in 2020. COPD is a collective term for such respiratory diseases as emphysema, chronic bronchitis and bronchiectasis, and affects around 24 million Americans.